2015, Number 2
<< Back Next >>
Correo Científico Médico 2015; 19 (2)
Aggressive fibromatosis in pediatric age
Chapman TV, Manzano J, Trinchet SRM, Hidalgo MY, Melo ALA, Sánchez del Campo HYE
Language: Spanish
References: 20
Page: 246-258
PDF size: 287.99 Kb.
ABSTRACT
Introduction: aggressive fibromatosis is an uncommon, benign and recurrent disease.
Objective: to characterize fibromatosis in patients attended al Provincial Pediatric Hospital of Holguín.
Method: a retrospective cross-sectional study on aggressive fibromatosis in children younger than 19 years old was done during 2002 to 2012.
Results: fibromatosis prevalence was 2.1 per 100 000 inhabitants. Females prevailed over males. The tumor was mainly localized in the gluteal region followed by the neck and the abdominal wall. The etiology was unknown in 75 % of cases. Fine needle aspiration biopsy was not useful for diagnosis. The initial treatment was 100 % surgical but incomplete; nevertheless, spontaneous regression of recurrence was seen in 50 % of cases. Chemotherapy and radiotherapy were applied to recurrence without successful results.
Conclusions: the procedure, as the first line of treatment, should be considered because of tumor spontaneous regression. Surgical resection degree of the tumor does not prevent recurrence.
REFERENCES
Yogesh Kumar S, Nita k. Desmoid tumor of the buttock in a preadolescent child. APSP J Case Rep. 2011 [citado 2 abr 2013]; 2(1):2.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3418014/
Pranay T, Nalini G, Rakesh Kumar V, Gurpreet S. Fine needle aspiration cytology in fibromatosis. J Citol. 2012[citado 10 abr 2013]; 29(1): 66–68.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307459/
Garrido C, López J, Palacios ME, Vivanco JL, Torres MJ, Valdivieso Melero C, et al. Fibromatosis agresiva en la infancia: Análisis retrospectivo de 4 casos. An Esp Pediatr.1998 [citado 10 abr 2013]; 49(1): 23-6. Disponible en: http://pesquisa.bvsalud.org/portal/resource/es/mdl-9718762
Oudot C, Orbach D, Minard Colin V, Michon J, Mary P, Glorion C, et al. Desmoid Fibromatosis in Pediatric Patients: Management Based on a Retrospective Analysis of 59 Patients and a Review of the Literature. Sarcoma. 2013; 475202. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3420075/
Pakos E, Tsekeris PG, Goussia AC. Desmoid tumours of the extremities and trunk: a review of the literature. Internat Orthop. 2005 [citado 10 abr 2013]; 29: 210–213.Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3474525/pdf/264_2005_Article_641.pdf
Gounder MM, Lefkowitz RA, Keohan ML, D’Adamo DR, Hameed M, Antonescu CR, et al. Activity of sorafenib against desmoid tumor/deep fibromatosis. Clin Cancer Res. 2011 [citado 12 abr 2013]; 17(12): 4082–4090. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3152981/
Tamayo Figueroa A, Silva Hernández CA, Barroso Álvarez MC, Ferrer NR, González Cabrera RD. Fibromatosis agresiva: aspectos clínicos, epidemiológicos y terapéuticos. Rev Cubana Oncol. 2001[citado 12 abr 2013]; 17(1):17-25. Disponible en: http://pesquisa.bvsalud.org/portal/resource/es/lil-331409
Dômont J, Salas S, Lacroix L, Brouste V, Saulnier P, Terrier P, et al. High frequency of β-catenin heterozygous mutations in extra-abdominal fibromatosis: a potential molecular tool for disease management. British J Cancer. 2010 [citado 5 abr 2013]; 102(6): 1032–1036. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2844024/
Kohli K, Kawatra Vi, Khurana N, Jain S. Multicentric synchronous recurrent aggressive fibromatosis. J Cytol. 2012[citado 5 abr 2013]; 29(1): 57–59. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3307455/
Hong H, Nadesan P, Poon R, Alman BA. Testosterone regulates cell proliferation in aggressive fibromatosis (desmoid tumour). Br J Cancer. 2011[citado 5 abr 2013]; 104(9): 1452–1458. [citado 5 abr 2011]. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3101926/
Molloy AP, Hutchinson B, O’ Toole GC. Extra Abdominal Desmoid Tumours: A Review of the Literature. Sarcoma. 2012[citado 5 abr 2013]; 578052. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3431123/
Kotiligam D, Lazar AJ, Pollock RE, Lev D. Desmoid tumor: a disease opportune for molecular insights. Histol Histopathol. 2008[citado 5 abr 2011]; 23(1):117-26. Disponible en: http://www.hh.um.es/Abstracts/Vol_23/23_1/23_1_117.htm
Wang WL, Nero C, Pappo A, Lev D, Lazar AJ, López Terrada D. CTNNB1 genotyping and APC screening in pediatric desmoid tumors: a proposed algorithm. Pediatr Dev Pathol. 2012; 15(5):361-7. Disponible en: http://www.pedpath.org/doi/abs/10.2350/11-07-1064-OA.1?journalCode=pdpa
Akira K, Akira K, Tsukasa K, Toru H. Extraabdominal fibromatosis in retroperitoneal space. World J Surg Oncol. 2004 [citado 5 abr 2013]; 2: 33. Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC524188/
Dufresne A, Bertucci F, Penel N, Le Cesne A, Bui B, Tubiana Hulin M, et al. Identification of biological factors predictive of response to imatinib mesylate in aggressive fibromatosis. Br J Cancer. 2010 [citado 5 abr 2013]; 103(4): 482–485 Disponible en: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2939782/
Nakayama T, Tsuboyama T, Toguchida J, Hosaka T, Nakamura T. Natural course of desmoid-type fibromatosis. J Orthop Sci. 2008[citado 5 abr 2013]; 13(1):51-5. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/18274856
Honeyman JN, Theilen TM, Knowles MA, McGlynn MM, Hameed M, Meyers P, et al. Desmoid fibromatosis in children and adolescents: a conservative approach to management. J Pediatr Surg. 2013[citado 5 abr 2013]; 48(1):62-6. Disponible en: http://www.ncbi.nlm.nih.gov/pubmed/23331794
Cuba. Ministerio de Salud Pública. Anuario estadístico de salud. La Habana: MINSAP; 2012.
Iaroshevskaia EN, Serkova MG, Ovsiankin NA, Kutuzov AP, Koniukhov MP. 2 local case of congenital fibromatosis. Arkh Patol.1990 [citado 5 abr 2013]; 52(1):64-6. http://pesquisa.bvsalud.org/portal/resource/es/mdl-2337396
Rutenberg MS, Indelicato DJ, Knapik JA, Lagmay JP, Morris C, Zlotecki RA, et al. External beam radiotherapy for pediatric and young adult desmoid tumors. Pediatr Blood Cancer. 2011 [citado 5 abr 2013]; 75(3):435-42. Disponible en: http://www.redjournal.org/article/S0360-3016%2809%2901158-4/abstract